Search

Issue
Title
Authors
Factors associated with a reduction in glomerular filtration rate in patients with chronic obstructive pulmonary disease
Bolotova E.V., Dudnikova A.V.
Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
Salukhov V.V., Shamkhalova M.S., Duganova A.V.
Nephropathy in Fabry disease: possibilities for the radical improvement of prognosis for orphan diseases
Fomin V.V., Pulin A.A., Mukhin N.A.
Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review
Golovina E.L., Vaizova O.E., Meleshko M.V., Samoilova I.G., Podchinenova D.V., Borozinets A.A., Matveeva M.V., Kudlay D.A.
The agreed experts’ position of the Eurasian Association of Therapists on tactics of management of patients with comorbid pathology infected with SARS-Cov-2
Arutiunov G.P., Tarlovskaia E.I., Koziolova N.A., Boldina M.V., Batiushin M.M., Ametov A.S., Arutiunov A.G., Belevskii A.S., Galstian G.R., Grigor’eva N.I., Dzhunusbekova G.A., Esaian A.M., Mal’chikova S.V., Mit’kovskaia N.P., Mkrtumian A.M., Orlova I.A., Petrova M.M., Rebrov A.P., Ruzanov D.I., Salukhov V.V., Sisakian A.S., Skibitskii V.V., Sugraliev A.B., Fomin I.V., Khalimov I.S., Chesnikova A.I., Shaposhnik I.I., Shestakova M.V.
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
Maevskaya M.V., Kotovskaya Y.V., Ivashkin V.T., Tkacheva O.N., Troshina E.A., Shestakova M.V., Breder V.V., Geyvandova N.I., Doshchitsin V.L., Dudinskaya E.N., Ershova E.V., Kodzoeva K.B., Komshilova K.A., Korochanskaya N.V., Mayorov A.Y., Mishina E.E., Nadinskaya M.Y., Nikitin I.G., Pogosova N.V., Tarzimanova A.I., Shamkhalova M.S.
Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease
Shakhmatova O.O., Komarov A.L., Krivosheeva E.N., Dobrovolsky A.B., Titaeva E.V., Amelyushkina V.A., Gomyranova N.V., Panchenko E.P.
Clinicopatological variants and risk factors for chronic kidney disease in rheumatoid arthritis
Chebotareva N.V., Gulyaev S.V., Androsova T.V., Popova E.N., Gurova D.V., Novikov P.I., Milovanova L.Y., Moiseev S.V.
Cystatin C and preclinical lesions in the target organs of hypertensive patients
Oshchepkova E.V., Dmitriev V.A., Titov V.N.
Hyperuricemia and kidney damage in patients with cardiovascular disease: A review
Mironova O.I.
Predictors of clinical events in patients with Fabry disease: the role of chronic kidney disease
Moiseev S.V., Karovaikina E.A., Bulanov N.M., Moiseev A.S., Fomin V.V.
Resolution of the Expert Forum "New therapeutic horizons of NAFLD"
Drapkina O.M., Martynov A.I., Arutyunov G.P., Bakulin I.G., Livzan M.A., Maev I.V., Egorov I.V.
The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction
Karetnikova V.N., Kalaeva V.V., Evseeva M.V., Osokina A.V., Kashtalap V.V., Gruzdeva O.V., Shafranskaya K.S., Zykov M.V., Barbarash O.L.
Empagliflozin and heart failure: position paper of the experts on the results of the online meeting and discussion of the EMPEROR-Preserved Trial
Arutyunov G.P., Lopatin Y.M., Ametov A.S., Ageev F.T., Antsiferov M.B., Villevalde S.V., Vinogradova N.G., Galstyan G.R., Galyavich A.S., Gilyarevskiy S.R., Glezer M.G., Zhirov I.V., Ilyin M.V., Lebedeva A.I., Nedogoda S.M., Salukhov V.V., Tarlovskaya E.I., Tereshchenko S.N., Fomin I.V., Khalimov I.S., Khasanov N.R., Cherkashin D.V., Yakushin S.S.
Motivation for treatment in patients with chronic cardiorenal syndrome
Efremova E.V., Shutov A.M., Borodulina E.O.
Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease
Demyanova K.A., Kozlovskaya N.L., Korotchaeva Y.V., Apresyan S.V., Rylceva L.P., Usatenko G.V., Lugovoj A.O., Vorobyeva M.A., Bondarenko T.V., Bespalova A.V., Volkova O.A.
Long-term outcomes and formation of chronic disease of the kidneys in patients with a history of hemorrhagic fever with renal syndrome
Dudarev M.V., Pimenov L.T.
End products of glycation (AGEs) and inflammation in the clinic of cardiovascular complications and vascular calcification at different stages of chronic kidney disease (G1–G5D)
Fatima D.U., Remizov O.V., Ikoeva Z.R., Tedeeva I.V., Gusalov A.A., Goloeva V.G.
The relationship of hypertriglyceridemia and left ventricular remodeling types in patients with chronic kidney disease
Murkamilov I.T., Sabirov I.S., Fomin V.V., Aitbaev K.A., Murkamilova Z.A.
Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection
Milovanov Y.S., Mukhin N.A., Kozlovskaya L.V., Milovanova S.Y., Markina M.M.
Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease
Milovanova L.I., Milovanov I.S., Kozlovskaia L.V., Mukhin N.A.
Efficiency and safety of lipid-lowering therapy for chronic kidney disease
Kolina I.B., Stavrovskaia E.V.
Experience with ebrantil used in patients with resistant arterial hypertension in chronic kidney disease
Semenova R.I., Musina N.S.
ENDOTHELIAL DYSFUNCTION AND APOPTOSIS AT EARLY STAGE OF CHRONIC KIDNEY DISEASE
Smirnov A.V., Petrischev N.N., Mnuskina M.M., Panina I.Y., Pumyantsev A.S., Vasina E.Y., Achkasova V.V., Menshutina M.A.
Current methods for measuring the glomerular filtration rate in persons with normal weight and overweight
Novikova M.S., Kutyrina I.M., Shilov E.M., Novikova M.S., Kutyrina I.M., Shilov E.M.
Nephroprotective role of early correction of impaired nutritional status in patients with chronic disease of the kidneys at a predialysis stage
Milovanov I.S., Kozlovskaia L.V., Milovanova L.I.
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review
Bobkova I.N.
Prevalence, age and gender features of chronic kidney disease in patients with diabetes mellitus
Murkamilov I.T., Aitbaev K.A., Fomin V.V.
Serum troponin-I as a marker of fibroblast growth factor-23 (FGF-23) cardiotoxic effect, in patients with chronic kidney disease
Taranova M.V., Milovanova L.Y., Kozlovskaya(Lysenko) L.V., Milovanova S.Y., Androsova T.V., Zubacheva D.O., Lebedeva M.V., Dobrosmyslov I.A., Kozlov V.V., Kuchieva A.M., Li O.A., Reshetnikov V.A.
Renal experiences of bariatric surgery in patients with type 2 diabetes mellitus
Larina I.I., Severina A.S., Shamkhalova M.S., Shestakova M.V.
Nephrological aspects of surgical weight correction in morbid obesity
Bobkova I.N., Gussaova S.S., Stavrovskaya E.V., Struve A.V.
Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum
Mukhin N.A., Glybochko P.V., Svistunov A.A., Fomin V.V., Kiyakbaev G.G.
Cardiorenal prognosis in kidney dysfunction patients undergoing cardiac surgery
Iskenderov B.G., Sisina O.N.
Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease
Vasilyeva M.P., Rudenko T.E., Kutyrina I.M., Solomakhina N.I.
Effect of eprosartan on the hemostatic system in patients with chronic kidney disease associated with hereditary thrombophilia
Kaliuzhin V.V., Sibireva O.F., Urazova O.I., Tkalich L.M., Zibnitskaia L.I., Kaliuzhina E.V., Sazonov É.A., Grankina V.I.
Test strip evaluation of albuminuria for the early detection of chronic kidney disease in persons at different risks (the experience of the Health Centers of the Moscow Region)
Nagaĭtseva S.S., Shaliagin I.D., Shvetsov M.I., Piagaĭ N.L., Ivanova E.S., Shilov E.M.
The level of endothelin-1 and reactivity of skin microvessels in patients with early stages of chronic kidney disease
Smirnov A.V., Petrishchev N.N., Panina I.Y., Mnuskina M.M., Achkasova V.V., Rumyantsev A.S., Menshutina M.A., Smirnov A.V., Petrischev N.N., Panina I.Y., Mnuskina M.M., Achkasova V.V., Rumyantsev A.S., Menshutina M.A.
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Dzgoeva F.U., Remizov O.V., Goloeva V.G., Ikoeva Z.R.
Glycemic control in patients with diabetes mellitus on hemodialysis
Lobanova K.G., Severina A.S., Martinov S.A., Shamkhalova M.S., Shestakova M.V.
Renal function in patients receiving long-term warfarin therapy: A five-year prospective follow-up
Zemlyanskaya O.A., Kropacheva E.S., Dobrovolsky A.B., Panchenko E.P.
Chronic kidney disease and vascular dementia
Mukhin N.A., Fomin V.V., Damulin I.V., Rogova I.V.
Significance of the factors of hypoxia and endothelial dysfunction in kidney injury in the presence of obesity
Galliamov M.G., Saginova E.A., Severova M.M., Samokhodskaia L.M., Krasnova T.N., Sholomova V.I., Sorokin I.D., Mukhin N.A.
Anemia and quality of life of chronic kidney disease patients on renal replacement therapy by programmed hemodialysis
Kotenko O.N., Abolyan L.V., Kuteinikov V.I., Vinogradov V.E., Fomin V.V.
Normoalbuminuric chronic kidney disease in diabetes
Klimontov V.V., Korbut A.I.
Diabetes mellitus and chronic kidney disease: Possibilities of prediction, early diagnosis, and nephroprotection in the 21st century
Shestakova M.V.
Acute glomerulonephritis in the 21st century
Mukhin N.A., Glybochko P.V., Svistunov A.A., Fomin V.V., Shilov E.M., Lysenko L.V.
Risk factors for and prognostic value of multifocal atherosclerosis in patients with diabetes mellitus
Gracheva S.A., Biragova M.S., Glazunova A.M., Klefortova I.I., Shamkhalova M.S., Dzhavelidze M.I., Soldatova T.V., Il'in A.V., Shestakova M.V., Tugeeva É.F., Buziashvili I.I.
The pathogenetic bases of cardiorenal syndrome
Beloglazova I.P., Mogutova P.A., Poteshkina N.G.
PHARMACOLOGICAL NEPHROPROTECTION IN CHRONIC KIDNEY DISEASE: CURRENT OPPORTUNITIES AND PERSPECTIVES (REVIEW OF FOREIGN LITERATURE)
Nikolaev A.Y.
The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys
Milovanov Y.S., Kozlovskaya L.V., Milovanova L.Y., Milovanov Y.S., Kozlovskaya L.V., Milovanova L.Y.
The role of balanced low-protein diet in inhibition of progression of predialysis chronic disease of the kidneys in systemic diseases
Milovanov Y.S., Lysenko L.V., Milovanova L.Y., Dobrosmyslov I.A., Milovanov Y.S., Lysenko L.V., Milovanova L.Y., Dobrosmyslov I.A.
Soy protein as part of a low-protein diet is a new direction in cardio- and nephroprotection in patients with 3B–4 stages of chronic kidney disease: prospective, randomized, controlled clinical study
Milovanova L.Y., Taranova M.V., Volkov A.V., Milovanova S.Y., Beketov V.D.
Diagnostic value of urinary biomarkers excretion in estimation of morphological lesions in patients with primary glomerulopathies
Saganova E.S., Zubina I.M., Bogdanova E.O., Galkina O.V., Sipovskii V.G., Smirnov A.V.
Anticoagulant therapy in patients with atrial fibrillation and reduced kidney function of diabetic and non-diabetic etiologies
Sokolova A.A., Daabul I.S., Tsarev I.L., Napalkov D.A., Fomin V.V.
Urinary excretion of angiogenesis regulatory factors and renal injury markers in chronic glomerulonephritis: Significance in the assessment of progression
Shvetsov M.Y., Zheng A., Kozlovskaya L.V., Serova A.G., Travkina E.V., Mukhin N.A.
The significance of natriuretic peptides in the evaluation of water-salt metabolism in chronic kidney disease
Pulin A.A., Kustova T.I., Fomin V.V., Mukhin N.A.
Hyperuricemia and the problem of chronic kidney disease
Shcherbak A.V., Kozlovskaia L.V., Bobkova I.N., Balkarov I.M., Lebedeva M.V., Stakhova T.I.
LONG-ACTING ERYTHROPOETIN EFFICACY IN THE TREATMENT OF NEPHROGENIC ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT A PREDIALYSIS STAGE
Milovanov Y.S., Milovanova L.Y.
Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho
Milovanova L.Y., Kozlovskaya L.V., Milovanov Y.S., Bobkova I.N., Dobrosmyslov I.A.
Correlations between the levels of vitamin D, parathormone, calcium, blood phosphates in patients with chronic disease of the kidneys untreated with replacement renal therapy
Smirnov A.V., Volkov M.M., Galkina O.V., Zhloba A.A., Emanuel' V.L., Smirnov A.V., Volkov M.M., Galkina O.V., Zhloba A.A., Emanel V.L.
State-of-the-art trends in the treatment of immune-mediated inflammatory kidney diseases: Translation of the fundamental science into clinical practice. A review
Bulanov N.M., Moiseev S.V.
Clinical significance of serum levels of osteoproteherin and sclerostin in assessment of vascular calcification in chronic kidney disease stage 3–5
Dzgoeva F.U., Remizov O.V., Botcieva V.K., Goloeva V.G., Malakhova N.G., Ikoeva Z.R.
Diabetes epidemiology in Russia: what has changed over the decade?
Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.A., Dedov I.I.
Endothelial dysfunction and arterial wall stiffness: New targets in diabetic nephropathy
Murkamilov I.T., Sabirov I.S., Fomin V.V., Yusupov F.A.
The role of immune factors in the progression of chronic kidney diseases in HIV infection
Yushchuk N.D., Gadzhikulieva M.M., Balmasova I.P., Volgina G.V., Gultyaev M.M.
Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease
Dzgoeva F.U., Sopoev M.Y., Gatagonova T.M., Bestaeva T.L., Khamitsaeva O.V.
New markers of cardio-renal links in chronic kidney disease
Milovanova L.I., Milovanov I.S., Kozlovskaia L.V., Mukhin N.A.
THE ROLE OF HYPERINSULINEMIA AND INSULIN RESISTANCE IN DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME
Kutyrina I.M., Kryachkova A.A., Savelieva S.A.
Treatment of diabetes mellitus in dialysis patients
Bondar' I.A., Klimontov V.V., Bondar I.A., Klimontov V.V.
Autonomic imbalance in patients with metabolic syndrome: role in the development of hyperfiltration, an early marker of renal lesion
Gornostayeva E.Y., Novikova M.S., Beloborodova A.V., Akarachkova E.S., Shilov E.M., Shvarkov S.B.
Effect of vitamin D receptor activators on serum Klotho levels in 3b–4 stages chronic кidney disease patients: a prospective randomized study
Milovanova L.Y., Beketov V.D., Milovanova S.Y., Taranova M.V., Kozlov V.V., Pasechnik A.I., Reshetnikov V.A., Androsova T.V., Kalashnikov M.V.
Circulating microRNAs as potential biomarkers of chronic kidney disease
Aitbaev K.A., Murkamilov I.T., Fomin V.V.
Adenoma of the parathyroid gland in a young woman with chronic kidney disease: primary or tertiary hyperparathyroidism?
Vetchinnikova O.N., Prokopenko E.I., Voronkova I.A.
Chronic kidney disease in rheumatoid arthritis patients: prevalence, risks factors, histopathological variants
Chebotareva N.V., Guliaev S.V., Androsova T.V., Milivanova L.U.
Risk factors for pulmonary hypertension at the predialysis stage of chronic kidney disease
Rudenko T.E., Vasilyeva M.P., Solomakhina N.I., Kutyrina I.M.
Increased serum concentrations of inflammatory cytokines in type 2 diabetic patients with chronic kidney disease
Konenkov V.I., Klimontov V.V., Myakina N.E., Tyan N.V., Fazullina O.N., Romanov V.V.
Experience with active vitamin D metabolites in phosphorus-calcium metabolic disorders in patients with predialysis chronic kidney disease
Milovanova L.I., Dobrosmyslov I.A., Milovanov I.S.
Phosphate binders in chronic kidney disease: The positions of sevelamer
Fomin V.V., Shilov E.M., Svistunov A.A., Milovanov I.S.
Diagnostic value of cystatin C and neutrophil gelatinase-associated lipocalin in primary glomerulopathies
Proletov I.I., Saganova E.S., Galkina O.V., Zubina I.M., Bogdanova E.O., Sipovskiĭ V.G., Smirnov A.V.
REMODELING OF CARDIOVASCULAR SYSTEM AND DEVELOPMENT OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND OBESITY: ROLE OF GENES ENOS, SUBUNIT P22-PHOX OF NADPH-OXIDASE AND MTHFR
Saginova E.A., Gallyamov M.G., Balatsky A.V., Kolotvin A.V., Severova M.V., Samokhodskaya L.M., Fomin V.V., Krasnova T.N., Mukhin N.A.
The role of major vessels remodeling in development of left ventricular hypertrophy in patients with a predialysis stage of chronic renal failure
Kutyrina I.M., Rudenko T.E., Shvetsov M.I., Kushnir V.V.
Progressiveazotemia provoked by ACE inhibitor in renal ischemia
Fomin V.V., Taronishvili О.I., Shvetsov M.Y., Shilov E.M., Moiseev S.V., Kushnir V.V., Sorokin Y.D.
Features of pregnancy after simultaneous pancreas-kidney transplantation in patient with type 1 diabetes mellitus. Case report
Yevloyeva M.I., Savitskaya D.U., Severina A.S., Shamkhalova M.S., Trubitsyna N.P., Shestakova M.V.
Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis
Markina M.V., Milovanova L.Y., Lysenko L.V., Milovanova S.Y., Volkov A.V., Beketov V.D., Lebedeva M.V., Nezhdanov K.S., Moiseev S.V.
COVID-19 in haemodialysis patients: result analysis of the first year of the pandemic
Zubkin M.L., Frolova N.F., Kim I.G., Ushakova A.I., Usatiuk S.S., Iskhakov R.T., Diakova E.N., Chervinko V.I., Volodina E.V., Tomilina N.A., Kryukov E.V.
Chronic kidney disease in the context of toxic effects the working chemical factors (literature review)
Strizhakov L.A., Fomin V.V., Garipova R.V., Babanov S.A., Arkhipov E.V., Lebedeva M.V.
Pentoxifylline and nephroprotection: effects on renal dysfunction and cardiovascular risks
Murkamilov I.T., Aitbaev K.A., Fomin V.V., Murkamilova Z.A., Bayzhigitova A.A.
Prognostic value of renal resistance index in estimating the progression of chronic kidney disease
Gazhonova V.E., Zykova A.S., Chistyakov A.A., Roshchupkina S.V., Romanova M.D., Krasnova T.N.
MYOCARDIAL REMODELING RISK FACTORS AT STAGE II-IV CHRONIC KIDNEY DISEASE
Rudenko T.E., Kutyrina I.M., Shvetsov M.Y.
1 - 89 of 89 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».